Dolores Shoback received her Bachelor’s Degree in Biology from the University of Pennsylvania and graduated from the Johns Hopkins University School of Medicine in 1977. She trained in Internal Medicine at the Johns Hopkins Hospital on the Osler Medical Service before completing a clinical and research fellowship in Endocrinology/Hypertension at Harvard Medical School in 1983. She joined the faculty of the University of California, San Francisco in 1985 in the Department of Medicine where she is currently Professor of Medicine and Staff Endocrinologist at the San Francisco Veterans Affairs Medical Center and Associate Director of the Diabetes, Endocrinology and Metabolism Fellowship Training Program at UCSF. She is engaged in research on the mechanisms underlying the regulation of parathyroid hormone secretion with specific interest in the role of calcium-sensing receptors in parathyroid cells and osteoblasts. Her clinical activities and clinical research interests focus on metabolic bone diseases, parathyroid disorders, and osteoporosis. She has participated in investigations into the role of calcium receptor activation in the control of parathyroid hormone hypersecretion due to primary hyperparathyroidism and parathyroid carcinoma and in clinical trials on the use of parathyroid hormone in the treatment of osteoporosis and as replacement therapy in the treatment of hypoparathyroidism. She has co-authored over 130 papers, reviews and editorials. She is currently Secretary-Treasurer of the Endocrine Society (2019-2022). She has participated in the development of guidelines for the management of primary hyperparathyroidism (2008, 2013), for pharmacologic treatment of postmenopausal osteoporosis for the Endocrine Society (2013-20), and for management of hypoparathyroidism in adults (2013-2015).